Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
br After several decades of
2019-05-13

After several decades of community-based interventions and surveillance, on Nov 15, 2016, Morocco was recognised by WHO as having eliminated trachoma as a public health problem. A formal ceremony, involving the handover of a letter of recognition from Margaret Chan, WHO\'s Director-General, marked
-
In our clinic the intracardiac electrogram recorded by
2019-05-13

In our clinic, the intracardiac electrogram recorded by the ICD showed repetitive non-reentrant ventriculoatrial synchrony (RNRVAS), which was associated with hypotension and chest discomfort (Fig. 1). We suspected that the RNRVAS caused the hypotension; therefore, we performed electrophysiologic an
-
In summary programmed long AVD prolonged VA conduction time
2019-05-10

In summary, programmed long AVD, prolonged VA conduction time caused by anti-arrhythmic medication, and the rate of ELT (110bpm, below the upper tracking rate of 120bpm) were the reason ELT continued even in the presence of a programmed ELT termination algorithm. Physicians who manage patients with
-
Early recognition of ICD lead malfunction is desirable to
2019-05-10

Early recognition of ICD lead malfunction is desirable to prevent the life-threatening consequences of lead failure. Recent reports indicate that the majority of patients with ICD lead failure experience inappropriate ICD therapies, often as the presenting problem [4,6]. Regular device interrogation
-
This patient presented to our emergency
2019-05-10

This patient presented to our emergency department with a three-day history of worsening headache six years after she was diagnosed with mixed adenoneuroendocrine carcinoma of the uterine cervix. Upon presentation, she reported rapidly progressive dizziness, vomiting and rightward deviation when wal
-
Aside from distinct technical approaches used
2019-05-10

Aside from distinct technical approaches used, the well-established RANKL and RANK expression patterns in the bone further substantiates the expression patterns defined in the current study of OS. RANKL and RANK play major roles in bone metabolism due to the critical role of this pathway in osteocla
-
Si recordamos que la edici n de El fistol del
2019-05-10

Si recordamos que la edición de El fistol del diablo es de 1887, y que la de Los bandidos de Río Frío de 1891, podemos deducir que en sus últimos años de vida, Payno concibió y planteó su idea del proceso histórico nacional en el que la tradición mexicana y la modernización nacional logran al fin un
-
AMG 925 En correspondencia con ese posicionamiento cr tico
2019-05-10

En correspondencia con ese posicionamiento crítico frente AMG 925 la propuesta de cambio social de sus respectivos gobiernos, los movimientos sociales tienen entre sus principales objetivos la autonomía material y simbólica, considerada una de las características comunes en el contexto de la amplia
-
People in LMICs are disproportionately exposed to severe
2019-05-10

People in LMICs are disproportionately exposed to severe acute kidney injury and have substantially less access to effective treatment than do people in higher-income countries. Framing acute kidney injury as a driver of substantial inequity in disease risk and mortality in low-resource countries, t
-
Aside from this report only two other
2019-05-10

Aside from this report, only two other studies of dexrazoxane use in adult AML patients have been published. In a series of seven patients with AML, Lemez and Maresova reported that the administration of dexrazoxane 30min before daunorubicin (dose 8-13x higher than daunorubicin) or mitoxantrone (dos
-
Reviewing the literature we knew that in
2019-05-10

Reviewing the literature, we knew that in cases of AA, use of IST should be cautious, as IST might accelerate occult lymphoma escaping immune surveillance and evolving as a refractory lymphoma. Second, in cases of AA and concomitant NHL, to choose cytotoxic chemotherapy or IST is an art. Depending o
-
In February a left neck infiltrating purpuric lesion
2019-05-09

In February 2013, a left neck infiltrating purpuric lesion around a previous surgical scar (lymph node biopsy) with mild pain was noted. A subsequent skin biopsy revealed metastatic adenocarcinoma, compatible with ampulla of Vater primary, thereby confirming disease progression with skin metastasis.
-
Introduction Multiple myeloma MM is the
2019-05-09

Introduction Multiple myeloma (MM) is the most frequent cancer to involve the skeleton with 80–90% of patients developing bone lesions during their disease course [1]. Myeloma bone lesions are purely osteolytic and are associated with severe and debilitating bone pain, pathologic fractures, hyperca
-
In the phase AZURE trial women were
2019-05-09

In the phase 3 AZURE trial, 3360 women were randomly assigned to receive standard adjuvant systemic treatment alone (control group) or with 4mg intravenous zoledronic Sunitinib every 3–4 weeks for 6 doses, then every 3 months for 8 doses, followed by every 6 months for 5 doses, for a total of 5 year
-
Preamble The J wave syndromes JWSs consisting
2019-05-09

Preamble The J-wave syndromes (JWSs), consisting of the Brugada syndrome (BrS) and early repolarization syndrome (ERS), have captured the interest of the cardiology mdm2 inhibitor over the past 2 decades following the identification of BrS as a new clinical entity by Pedro and Josep Brugada in 199
16849 records 1087/1124 page Previous Next First page 上5页 10861087108810891090 下5页 Last page